| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 |
| D0617 | TCI | 2,6-Diisopropylphenol | >98.0%(GC) | 340元/25G; 3140元/500G; | 展开 |
基本信息 | 纯度/分析方法 | >98.0%(GC) | | 分子式/分子量 | C12H18O = 178.28 | | 外观与形状(20℃) | 液体 | | 储存在惰性气体下 | 存放于惰性气体之中 | | 应避免的情况 | 空气 | | Reaxys-RN | 1866484 | | PubChem物质ID | 87567266 | | SDBS (AIST Spectral DB) | 862 | | Merck Index (14) | 7834 | | MDL编号 | MFCD00008885 |
技术规格 | Appearance | Colorless to Red to Green clear liquid | | Purity(GC) | min. 98.0 % |
物性(参考值) | 熔点 | 18 ℃ | | 沸点 | 242 ℃ | | 闪点 | 113 ℃ | | 比重 | 0.96 | | 折射率 | 1.51 |
安全信息 | 图形或危害标志 |   | | 信号词 | 警告 | | 危险性说明 | H302 : 吞咽有害。 H315 : 造成皮肤刺激。 H319 : 造成严重眼刺激。 H410 : 对水生生物毒性极大并具有长期持续影响。
| | 防范说明 | P501 : 将内装物/容器送到批准的废物处理厂处理。 P273 : 避免释放到环境中。 P270 : 使用本产品时不要进食、饮水或吸烟。 P264 : 作业后彻底清洗皮肤。 P280 : 戴防护手套/戴防护眼罩/戴防护面具。 P302 + P352 : 如皮肤沾染:用水充分清洗。 P391 : 收集溢出物。 P337 + P313 : 如仍觉眼刺激:求医/就诊。 P305 + P351 + P338 : 如进入眼睛:用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出,取出隐形眼镜。继续冲洗。 P362+P364 : 脱掉沾污的衣服,清洗后方可重新使用。 P332 + P313 : 如发生皮肤刺激:求医/就诊。 P301 + P312 + P330 : 如误吞咽:如感觉不适,呼叫急救中心/医生。漱口。
|
相关法规 运输信息 | UN编号 | UN3082 | | 类别 | 9 | | 包装类别 | III | | 监管条件代码(*) | |
|
| L06841 | Alfa Aesar | 2,6-Diisopropylphenol | 97% | 384元/25g; 2370元/100g; 6413元/500g; | 展开 |
应用 2,6-Diisopropylphenol plays the role of an antioxidant by reacting with free radicals to form a phenoxyl radical, a property associated with all phenol-based free radical scavengers. It is an effective intravenous hypnotic agent, widely used for the induction and maintenance of anesthesia and for sedation in the intensive care unit. It is useful for the induction and maintenance of general anaesthesia. 备注 Stable under recommended storage conditions. Incompatible with oxidizing agents. 基本信息 MDL MFCD00008885 EINECS 218-206-6 分子式 C12H18O 分子量 178.28 熔点 17-18° 沸点 254-256° 闪点 113°(235°F) 密度 0.962 折射率 1.5140 灵敏度 Ambient temperatures. 形态 Liquid 溶解性 Very slightly soluble in water. Beilstein 1866484 Merck 14,7834 GHS危害和防范说明 GHS符号
 Hazard Statements H302-H315-H319-H335 Harmful if swallowed.Causes skin irritation.Causes serious eye irritation.May cause respiratory irritation. Precautionary Statements P261-P280a-P305+P351+P338-P304+P340-P405-P501a Avoid breathing dust/fume/gas/mist/vapours/spray.Wear protective gloves and eye/face protection.IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing.Store locked up.Dispose of contents/container in accordance with local/regional/national/international regulations. 安全信息 UN# UN3145 危险等级 8 包装组 III 危险类别 22-36/37/38 Harmful if swallowed.Irritating to eyes, respiratory system and skin. 安全等级 23-26-36/37-60 Do not breathe gas/fumes/vapour/spray (appropriate wording to be specified by the manufacturer).In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.Wear suitable protective clothing and gloves.This material and its container must be disposed of as hazardous waste 欧盟危险品标志
 RTECS SL0810000 TSCA 是 |
| PHR1663 | Supelco | Propofol | Pharmaceutical Secondary Standard; Certified Reference Material | 2370.89元/1 ML; | 展开 |
产品说明 一般描述 Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Propofol is approved for induction and maintenance of paediatric anesthesia and sedation in children less than 3 years of age. The mechanism of action involves interaction with gamma-aminobutyric acid A receptor. Rapid effect and fewer side effects like postoperative nausea makes propofol a popular intravenous anesthetic agents. 应用 These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements. Propofol may be used as a pharmaceutical reference standard for the determination of the analyte in emulsion dosage form by sequential injection technique with spectrophotometric and fluorimetric detections. 分析说明 These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available. 其他说明 This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis. 附注 To see an example of a Certificate of Analysis for this material enter LRAA5999 in the Documents slot below. This is an example certificate only and may not be the lot that you receive. 基本信息 | 线性分子式 | [(CH3)2CH]2C6H3OH | | 分子量 | 178.27 | | EC 号 | 218-206-6 | | MDL编号 | MFCD00008885 | | PubChem化学物质编号 | 329823540 | | NACRES | NA.24 |
产品性质 | 质量水平 | 300 | | 等级 | certified reference material pharmaceutical secondary standard | | 蒸汽压 | 5.6 mmHg ( 100 ℃) | | CofA | current certificate can be downloaded | | 包装 | ampule of 1 mL | | technique(s) | HPLC: suitable gas chromatography (GC): suitable | | 折射率 | n20/D 1.514 (lit.) | | bp | 256 ℃/764 mmHg (lit.) | | mp | 18 ℃ (lit.) | | 密度 | 0.962 g/mL at 25 ℃ (lit.) | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 药典可追溯性 | traceable to BP 1031 traceable to PhEur Y0000016 traceable to USP 1572503 | | 储存温度 | 2-8℃ | | SMILES string | CC(C)c1cccc(C(C)C)c1O | | InChI | 1S/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H3 | | InChI key | OLBCVFGFOZPWHH-UHFFFAOYSA-N | | Gene Information | human ... GABRA1(2554), GABRA2(2555), GABRA3(2556), GABRA4(2557), GABRA5(2558), GABRA6(2559), GABRB1(2560), GABRB2(2561), GABRB3(2562), GABRD(2563), GABRE(2564), GABRG1(2565), GABRG2(2566), GABRG3(2567), GABRP(2568), GABRQ(55879) |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H302 - H315 - H319 - H335 | | 预防措施声明 | P261 - P264 - P270 - P301 + P312 - P302 + P352 - P305 + P351 + P338 | | 危险分类 | Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 10 - Combustible liquids | | WGK | WGK 3 | | 闪点(F) | 235.4 °F - closed cup | | 闪点(C) | 113 ℃ - closed cup |
|
| Y0000016 | | Propofol | European Pharmacopoeia (EP) Reference Standard | 1572.27元/ ; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 650 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 线性分子式 | [(CH3)2CH]2C6H3OH | | 分子量 | 178.27 | | MDL编号 | MFCD00008885 | | PubChem化学物质编号 | 329830815 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | 蒸汽压 | 5.6 mmHg ( 100 ℃) | | manufacturer/tradename | EDQM | | 折射率 | n20/D 1.514 (lit.) | | bp | 256 ℃/764 mmHg (lit.) | | mp | 18 ℃ (lit.) | | 密度 | 0.962 g/mL at 25 ℃ (lit.) | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | CC(C)c1cccc(C(C)C)c1O | | InChI | 1S/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H3 | | InChI key | OLBCVFGFOZPWHH-UHFFFAOYSA-N | | Gene Information | human ... GABRA1(2554), GABRA2(2555), GABRA3(2556), GABRA4(2557), GABRA5(2558), GABRA6(2559), GABRB1(2560), GABRB2(2561), GABRB3(2562), GABRD(2563), GABRE(2564), GABRG1(2565), GABRG2(2566), GABRG3(2567), GABRP(2568), GABRQ(55879) |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H302 - H315 - H319 - H335 | | 预防措施声明 | P261 - P264 - P270 - P301 + P312 - P302 + P352 - P305 + P351 + P338 | | 危险分类 | Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | 235.4 °F - closed cup | | 闪点(C) | 113 ℃ - closed cup |
|
| Y0000017 | | Propofol for peak identification | European Pharmacopoeia (EP) Reference Standard | 1277.32元/ ; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 0.1 mL. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 线性分子式 | [(CH3)2CH]2C6H3OH | | 分子量 | 178.27 | | MDL编号 | MFCD00008885 | | PubChem化学物质编号 | 329830816 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | 蒸汽压 | 5.6 mmHg ( 100 ℃) | | manufacturer/tradename | EDQM | | 折射率 | n20/D 1.514 (lit.) | | bp | 256 ℃/764 mmHg (lit.) | | mp | 18 ℃ (lit.) | | 密度 | 0.962 g/mL at 25 ℃ (lit.) | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | CC(C)c1cccc(C(C)C)c1O | | InChI | 1S/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H3 | | InChI key | OLBCVFGFOZPWHH-UHFFFAOYSA-N | | Gene Information | human ... GABRA1(2554), GABRA2(2555), GABRA3(2556), GABRA4(2557), GABRA5(2558), GABRA6(2559), GABRB1(2560), GABRB2(2561), GABRB3(2562), GABRD(2563), GABRE(2564), GABRG1(2565), GABRG2(2566), GABRG3(2567), GABRP(2568), GABRQ(55879) |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H302 - H315 - H319 - H335 | | 预防措施声明 | P261 - P264 - P270 - P301 + P312 - P302 + P352 - P305 + P351 + P338 | | 危险分类 | Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 10 - Combustible liquids | | WGK | WGK 3 | | 闪点(F) | 235.4 °F - closed cup | | 闪点(C) | 113 ℃ - closed cup |
|
| D126608 | Sigma-Aldrich | 2,6-Diisopropylphenol | 97% | 431.63元/5 G; 1701.97元/100 G; | 展开 |
产品说明 一般描述 2,6-二异丙基苯酚(一种强疏水取代苯酚)是一种新型静脉麻醉剂。已研究 2,6-二异丙基苯酚(异丙酚)的抗氧化属性。2,6-二异丙基苯酚是一种有效的静脉注射催眠药,广泛用于麻醉诱导和维持以及重症监护病房的镇静。用于全身麻醉的诱导和维持。 应用 2,6-二异丙基苯酚是研究其对离体大鼠肝线粒体氧化磷酸化作用的合适试剂。是制备双(2,6-二异丙基苯氧基)双(2-甲基-8-喹啉)钛 (IV) 配合物的合适试剂。 包装 5, 100 g in glass bottle 基本信息 | 线性分子式 | [(CH3)2CH]2C6H3OH | | 分子量 | 178.27 | | EC 号 | 218-206-6 | | MDL编号 | MFCD00008885 | | PubChem化学物质编号 | 24278001 | | NACRES | NA.22 |
产品性质 | 蒸汽压 | 5.6 mmHg ( 100 ℃) | | 质量水平 | 100 | | 测定 | 97% | | 折射率 | n20/D 1.514 (lit.) | | bp | 256 ℃/764 mmHg (lit.) | | mp | 18 ℃ (lit.) | | 密度 | 0.962 g/mL at 25 ℃ (lit.) | | SMILES string | CC(C)c1cccc(C(C)C)c1O | | InChI | 1S/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H3 | | InChI key | OLBCVFGFOZPWHH-UHFFFAOYSA-N | | Gene Information | human ... CYP1A2(1544), GABRA1(2554), GABRA2(2555), GABRA3(2556), GABRA4(2557), GABRA5(2558), GABRA6(2559), GABRB1(2560), GABRB2(2561), GABRB3(2562), GABRD(2563), GABRE(2564), GABRG1(2565), GABRG2(2566), GABRG3(2567), GABRP(2568), GABRQ(55879) rat ... Gabra2(29706) |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H302 - H315 - H319 - H335 | | 预防措施声明 | P261 - P264 - P270 - P301 + P312 - P302 + P352 - P305 + P351 + P338 | | 危险分类 | Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 10 - Combustible liquids | | WGK | WGK 3 | | 闪点(F) | 235.4 °F - closed cup | | 闪点(C) | 113 ℃ - closed cup | | 个人防护装备 | Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter |
|
| BP1031 | | Propofol | British Pharmacopoeia (BP) Reference Standard | 2244.51元/1 ML; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 1 mL. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息 | 线性分子式 | [(CH3)2CH]2C6H3OH | | 分子量 | 178.27 | | EC 号 | 218-206-6 | | MDL编号 | MFCD00008885 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | 蒸汽压 | 5.6 mmHg ( 100 ℃) | | manufacturer/tradename | BP | | 折射率 | n20/D 1.514 (lit.) | | bp | 256 ℃/764 mmHg (lit.) | | mp | 18 ℃ (lit.) | | 密度 | 0.962 g/mL at 25 ℃ (lit.) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | CC(C)c1cccc(C(C)C)c1O | | InChI | 1S/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H3 | | InChI key | OLBCVFGFOZPWHH-UHFFFAOYSA-N | | Gene Information | human ... GABRA1(2554), GABRA2(2555), GABRA3(2556), GABRA4(2557), GABRA5(2558), GABRA6(2559), GABRB1(2560), GABRB2(2561), GABRB3(2562), GABRD(2563), GABRE(2564), GABRG1(2565), GABRG2(2566), GABRG3(2567), GABRP(2568), GABRQ(55879) |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H302 - H315 - H319 - H335 | | 预防措施声明 | P261 - P264 - P270 - P301 + P312 - P302 + P352 - P305 + P351 + P338 | | 危险分类 | Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 10 - Combustible liquids | | WGK | WGK 3 | | 闪点(F) | 235.4 °F - closed cup | | 闪点(C) | 113 ℃ - closed cup |
|
| 1572503 | USP | Propofol | United States Pharmacopeia (USP) Reference Standard | 3231.47元/500 MG; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. Sales restrictions may apply. 基本信息 | 线性分子式 | [(CH3)2CH]2C6H3OH | | 分子量 | 178.27 | | MDL编号 | MFCD00008885 | | PubChem化学物质编号 | 329750986 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | 蒸汽压 | 5.6 mmHg ( 100 ℃) | | manufacturer/tradename | USP | | 折射率 | n20/D 1.514 (lit.) | | bp | 256 ℃/764 mmHg (lit.) | | mp | 18 ℃ (lit.) | | 密度 | 0.962 g/mL at 25 ℃ (lit.) | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | CC(C)c1cccc(C(C)C)c1O | | InChI | 1S/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H3 | | InChI key | OLBCVFGFOZPWHH-UHFFFAOYSA-N | | Gene Information | human ... GABRA1(2554), GABRA2(2555), GABRA3(2556), GABRA4(2557), GABRA5(2558), GABRA6(2559), GABRB1(2560), GABRB2(2561), GABRB3(2562), GABRD(2563), GABRE(2564), GABRG1(2565), GABRG2(2566), GABRG3(2567), GABRP(2568), GABRQ(55879) |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H302 - H315 - H319 - H335 | | 预防措施声明 | P261 - P264 - P270 - P301 + P312 - P302 + P352 - P305 + P351 + P338 | | 危险分类 | Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 10 - Combustible liquids | | WGK | WGK 3 | | 闪点(F) | 235.4 °F - closed cup | | 闪点(C) | 113 ℃ - closed cup |
|